Page last updated: 2024-09-05

2-(4-morpholinoanilino)-6-cyclohexylaminopurine and decitabine

2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with decitabine in 1 studies

Compound Research Comparison

Studies
(2-(4-morpholinoanilino)-6-cyclohexylaminopurine)
Trials
(2-(4-morpholinoanilino)-6-cyclohexylaminopurine)
Recent Studies (post-2010)
(2-(4-morpholinoanilino)-6-cyclohexylaminopurine)
Studies
(decitabine)
Trials
(decitabine)
Recent Studies (post-2010) (decitabine)
850623,8042052,177

Protein Interaction Comparison

ProteinTaxonomy2-(4-morpholinoanilino)-6-cyclohexylaminopurine (IC50)decitabine (IC50)
DNA (cytosine-5)-methyltransferase 1Homo sapiens (human)0.03

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdulrantam, F; Hendrianto, E; Pikir, BS; Susilowati, H1

Other Studies

1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and decitabine

ArticleYear
Reversin increase the plasticity of bone marrow-derived mesenchymal stem cell for generation of cardiomyocyte in vitro.
    Acta medica Indonesiana, 2012, Volume: 44, Issue:1

    Topics: Animals; Antigens, CD34; Azacitidine; Biomarkers; Bone Marrow Cells; Cardiac Myosins; Cell Dedifferentiation; Cell Transdifferentiation; Cells, Cultured; Decitabine; GATA4 Transcription Factor; Male; Mesenchymal Stem Cells; Morpholines; Myocytes, Cardiac; Myosin Light Chains; Proto-Oncogene Proteins c-kit; Purines; Rabbits; Reverse Transcriptase Polymerase Chain Reaction

2012